Task order 13
Ended Awarded Last action
- Contract number
- HHSN26100013
- Awardee
-
Societal Cdmo San Diego, LLC UEI YRPTVKHDL7Z5 Part of Irisys, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $70,868
Award facts
- Opportunity
-
- N02CM5700205 Solicitation number
- Manufacture of Oral and Topical Dosage Forms Award Notice · Posted Jul 6, 2015
- Manufacture of Oral and Topical Dosage Forms Award Notice · Posted Jan 6, 2015
- Contract value 100% obligated
- $70,868.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Original award | $70,868 |
About this award
This is a federal contract award from the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC, doing business as Irisys Inc. The $70,868 task order is for the manufacture of oral and topical dosage forms on a cost-plus-fixed-fee basis.
Societal CDMO San Diego, a small disadvantaged business, is a contract development and manufacturing organization (CDMO) that provides pharmaceutical development, manufacturing, and testing services to federal agencies. The company has supported the NCI and other NIH institutes through multiple federal contract vehicles, including a $45 million multiple-award Indefinite Delivery Vehicle (IDV) for drug formulation and manufacturing.
This particular task order does not have a set-aside designation. The work to be performed includes production of various investigational drug products, such as metarrestin, z-endoxifen, AZA-TDC, and TAK-243, as well as stability testing and analytical services to support the NCI's clinical research and drug development efforts in oncology and other therapeutic areas.
Quick answers
Who was awarded contract HHSN26100013?
HHSN26100013 was awarded to Societal Cdmo San Diego, LLC by National Cancer Institute (National Institutes of Health) on July 18, 2016.
How much is contract HHSN26100013 worth?
The government has obligated $70,868 on HHSN26100013.
Is contract HHSN26100013 an order under another contract?
Yes. HHSN26100013 is a delivery order under HHSN261201500009I, an indefinite delivery contract.
Was contract HHSN26100013 competed?
The extent of competition for HHSN26100013 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award